Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
30 Stocks Moving in Thursday's Pre-Market Session
Gainers Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales. The ExOne Company (NASDAQ... 
Via Benzinga
Zomedica Is an Excellent Spec Play After Falling
ZOM stock is trading at a discount, which means this is the perfect time for investors to trade this one for short-term profits. 
Via InvestorPlace
Time Is Passing Too Slowly For Zomedica Speculators
Zomedica speculators are being told to be patient, but there's a time cost to money and some will likely let ZOM stock go soon. 
Via InvestorPlace
There’s Little That’s Attractive About Once-Hot Zomedica Stock… for Now
Zomedica has become a slow-motion train wreck. ZOM stock investors should look for alternatives to the animal diagnostics firm. 
Via InvestorPlace
Zomedica Stock Might Not Appeal To Millennials as Much as Some Hope
While young people own pets, the question for ZOM stock is whether they will truly care for them. 
Via InvestorPlace
Avoid Zomedica Stock As It’s Bogged Down By Too Many Red Flags
Resignation of Zomedica's President and CMO, and the CEO are red flags. Wait to buy ZOM stock until 30 cents for a margin of safety. 
Via InvestorPlace
Zomedica Is Still Working Out How to Sell Truforma. Can Investors Afford to Wait?
Zomedica came public too soon, but it does have enough cash to see a finish line. The question is, can ZOM stock investors afford to wait? 
Via InvestorPlace
Ignore Zomedica’s Recent Struggles. The Road Ahead Remains Bright.
ZOM stock has come under price pressure recently, but the outlook is bright as Zomedica plots a road map to success. 
Via InvestorPlace
Speculative Investors Are Crazy Not to Buy Zomedica at Its Current Prices
Under 75 cents, ZOM stock is a penny stock worth betting on 
Via InvestorPlace
Wait for Zomedica to Give Up More of its Meme Stock Gains
It's not there yet, but if ZOM stock pulls back another 50% or so, the risk/return proposition will be more in your favor. 
Via InvestorPlace
Zomedica Stock Still Has a Rocky Few Months Left Ahead of It
ZOM stock is rife with massive potential. But it's the same potential that has gone unfulfilled for the past few months. 
Via InvestorPlace
A Little Patience Could Go a Long Way For ZOM Stock
Now that Truforma is in the market, it’s time for investors to see revenue growth 
Via InvestorPlace
2 Risky Meme Stocks You Don't Want to Hold With 'Diamond Hands'
Some stocks you can buy and forget. With Zomedica and ContextLogic, you'll want to keep a much closer eye on matters. 
Via The Motley Fool
Wait for the Reddit Set to Sell Before Buying Bionano Stock
Genomics play BNGO stock may pay off down the road, but wait for a meme stock investor exodus before making it a buy 
Via InvestorPlace
Zomedica Is Way Undervalued Here as Its Gear Is Catching On
InvestorPlace’s Mark Hake estimates Zomedica is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy. Here’s why I agree. 
Via InvestorPlace
Radio Silence May Indicate a Problem for Zomedica Stock
Zomedica is due to report results for the current quarter on Aug. 11. Until then, investors have nothing with which to weigh ZOM stock. 
Via InvestorPlace
Zomedica Stock Has More Headwinds Than the Rest of the Pet Industry
Drilling into pet industry details reveals a key risk factor that some ZOM stock believers may be ignoring. 
Via InvestorPlace
Risk-Reward Ratio of Zomedica Stock Looks Unfavorable
Zomedica may be facing tough competition, and there are indications that Truforma is not popular so far. ZOM stock looks very risky. 
Via InvestorPlace
Zomedica Pharmaceuticals Has to Prove Itself to Long-Term Investors
The hype surrounding ZOM stock has worn off, and it's now time for the company to prove its value through its sales numbers. 
Via InvestorPlace
Zomedica Is Good Value and May Be Worth $1.36 — Or More
Zomedica is good value and is on the acquisition warpath. ZOM stock is worth $1.36 on average, providing an average 20% ROI over 2 years. 
Via InvestorPlace
Zomedica Is Surprisingly Cheap Even as Commercialization Commences
ZOM stock has spiked sharply this year, but a recent price pullback could signal an ideal entry point for pet care market investors. 
Via InvestorPlace
Better Robinhood Penny Stock: Sundial Growers vs. Zomedica
Both have been huge winners in recent months. 
Via The Motley Fool
Zomedica’s Risks Are Too Big to Ignore
You may like ZOM stock as a pet lover, but not for its fundamentals, nor its valuation until it starts having credible financial results. 
Via InvestorPlace
Zomedica’s High Share Count Creates Challenges for ZOM Stock
Zomedica has promising growth potential, but its high share count makes ZOM stock a risky investment. Here's what investors should know. 
Via InvestorPlace
Topics Bonds
Exposures Debt Markets
Zomedica Stock Will Be Worth The Risk After Another Drop
Another pullback in ZOM stock will put this long-term speculative play's odds in your favor if its Truforma product catches on. 
Via InvestorPlace
Right-Priced Zomedica Could Be an Investor’s Best Friend
The skeptics might misinterpret the company's first-quarter revenue data, but a deeper dive should uncover reasons to hold on to ZOM stock. 
Via InvestorPlace
Exposures COVID-19
Social Distancing Creates Pet-Buying Boom that Sends the Industry to New Heights
Via FinancialNewsMedia
Bets on Zomedica’s In-Office Vet Test Could Payoff or Bust by Year-End
ZOM stock is pure speculation as pet owners are spending more on keeping their dogs and cats alive. 
Via InvestorPlace
Is Zomedica Making a Change For the Better?
Wait for evidence of success before making a speculative bet on ZOM stock 
Via InvestorPlace
Zomedica Stock Can Return to a Dollar If It Focuses on Just One Thing
Zomedica is testing its support levels at current prices. What does the maker of diagnostic equipment need to do to get ZOM stock back to $1? 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.